摘要
背景:目前研究DNA与小分子药物的相互作用,既可以探索其作用机制,也可以开发新的药物。电化学生物传感器以其快速、低成本、简单、灵敏度高、与不同环境下的使用兼容等优点,为传统药物检测技术提供了一种非常有前途的替代方法。本文简要综述了迄今为止用于药物和非法药物检测的电化学核酸生物传感方法,讨论了它们的基本原理和主要特点。文中还指出了这一领域的一般结论和今后的发展方向。结果:选择的42份材料描述了通过监测药物与核酸(DNA和适配体)的特定相互作用、DNA损伤和特定的DNA-蛋白质相互作用来确定感兴趣药物的电化学平台。重点介绍的方法报告了未经修饰或修饰的纳米材料和/或聚合物电极的使用情况,在这些电极中,DNA与药物相互作用之后电化学检测DNA Puric碱、活性药物或无扩散标记,并利用不同的电化学技术监测表层形貌/渗透性和电荷转移电阻的变化。结论:虽然电化学核酸生物传感方法在成本、简单性和小型化仪器等方面是药物测定的一个有趣的选择,但仍需要用常规方法详尽地验证其在实际样品中的性能,并将其应用于便携式和自动化的高通量器件中,同时探索纳米材料和聚合物的新型电极修饰,并更详细地研究它们对大量分析物质的复用能力。
关键词: 电化学传感器,核酸,药物,DNA损伤,纳米材料,聚合物。
Current Medicinal Chemistry
Title:Electrochemical Nucleic Acid-Based Biosensing of Drugs of Abuse and Pharmaceuticals
Volume: 25 Issue: 33
关键词: 电化学传感器,核酸,药物,DNA损伤,纳米材料,聚合物。
摘要: Background: Studies on the interactions of DNA with small molecular drugs are currently performed both to explore their mechanism of action and to develop new drugs. Electrochemical biosensors offer a very promising alternative to more complex conventional techniques for drug determination due to rapidness, low cost, simplicity, high sensitivity and compatibility with use in different settings. In this review, selected electrochemical nucleic acid-based biosensing methods described so far for the determination of pharmaceuticals and illicit drugs are briefly overviewed, discussing their basics and main features. A section pointing out general conclusions and future directions in this field is also provided.
Results: The 42 selected contributions described electrochemical platforms to determine drugs of interest by monitoring their specific interactions with nucleic acids (DNA and aptamers), DNA damage and specific DNA-protein interactions. The highlighted approaches reported the use of electrodes unmodified or modified with nanomaterials and/or polymers in which DNA-drug interaction was followed by electrochemical detection of DNA puric bases, active drug or diffusion-free markers, and monitoring changes in the surface layer morphology/permeability and charge transfer resistance using different electrochemical techniques.
Conclusion: Although electrochemical nucleic acid biosensing approaches constitute an interesting option for drugs determination in terms of cost, simplicity and miniaturized instrumentation, validating exhaustively their performance in real samples against conventional methodologies and implementing them into portable and automatic high throughput devices, together with exploring novel electrode modifications with nanomaterials and polymers and studying in more detail their multiplexing ability for analysis of a large number of analytes, is still needed.
Export Options
About this article
Cite this article as:
Electrochemical Nucleic Acid-Based Biosensing of Drugs of Abuse and Pharmaceuticals, Current Medicinal Chemistry 2018; 25 (33) . https://dx.doi.org/10.2174/0929867324666171121103156
DOI https://dx.doi.org/10.2174/0929867324666171121103156 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Use of MHC II Structural Features in the Design of Vaccines for Organ-Specific Autoimmune Diseases
Current Pharmaceutical Design Redox-active and Redox-silent Compounds: Synergistic Therapeutics in Cancer
Current Medicinal Chemistry Crosstalk between IGF Signaling and Steroid Hormone Receptors in Breast Cancer
Current Pharmaceutical Design Corticotropin-Releasing Factor Receptor Antagonists in Affective Disorders and Drug Dependence - An Update
CNS & Neurological Disorders - Drug Targets Sirtuins: Possible Clinical Implications in Cardio and Cerebrovascular Diseases
Current Drug Targets Multiple-Target Drugs: Inhibitors of Heat Shock Protein 90 and of Histone Deacetylase
Current Drug Targets The Ubiquitin+Proteasome Protein Degradation Pathway as a Therapeutic Strategy in the Treatment of Solid Tumor Malignancies
Anti-Cancer Agents in Medicinal Chemistry Celastrus Orbiculatus Extract Potentiates the Sensitivity of Cisplatin Via Caspase-Depenent Apoptosis in Gastric Cancer
Anti-Cancer Agents in Medicinal Chemistry Bioconjugation of Polymers: A Novel Platform for Targeted Drug Delivery
Current Pharmaceutical Design Smart Synthetic Polymer Nanocarriers for Controlled and Site-Specific Drug Delivery
Current Topics in Medicinal Chemistry Novel Molecular Targets in Cancer Chemotherapy Waiting for Discovery
Current Medicinal Chemistry - Anti-Cancer Agents Structural Basis for Therapeutic Intervention of uPA/uPAR System
Current Drug Targets Targeting Bcl-2 Family of Proteins: An Important Strategy in Cancer Therapeutics
Current Chemical Biology Synthesis and Biological Evaluation of Triazole-Vanillin Molecular Hybrids as Anti-Cancer Agents
Current Bioactive Compounds Cannabinoids and Myocardial Ischemia: Novel insights, Updated Mechanisms, and Implications for Myocardial Infarction
Current Medicinal Chemistry Psoralen: A Biologically Important Coumarin with Emerging Applications
Mini-Reviews in Medicinal Chemistry Nucleic Acid Aptamers: Clinical Applications and Promising New Horizons
Current Medicinal Chemistry miR-15b and miR-21 as Circulating Biomarkers for Diagnosis of Glioma
Current Genomics The Intestinal Environment in Health and Disease – Recent Insights on the Potential of Intestinal Bacteria to Influence Human Health
Current Pharmaceutical Design The Connections Among Autophagy, Inflammasome and Mitochondria
Current Drug Targets